Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
26.64
-0.03 (-0.11%)
At close: Aug 1, 2025, 4:00 PM
26.64
0.00 (0.00%)
After-hours: Aug 1, 2025, 7:00 PM EDT

Company Description

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

It also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products.

The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands.

It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies.

The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013.

Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Perrigo Company plc
Perrigo Company logo
CountryIreland
Founded1887
IPO DateDec 16, 1991
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees8,379
CEOPatrick Lockwood-Taylor

Contact Details

Address:
The Sharp Building, Hogan Place
Dublin, D02 TY74
Ireland
Phone353 1 709 4000
Websiteperrigo.com

Stock Details

Ticker SymbolPRGO
ExchangeNYSE
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001585364
CUSIP NumberG97822103
ISIN NumberIE00BGH1M568
SIC Code2834

Key Executives

NamePosition
Patrick Lockwood-TaylorPresident, Chief Executive Officer and Director
Eduardo Guarita BezerraExecutive Vice President and Chief Financial Officer
Ronald C. JanishChief Transformation Officer
Catherine C. B. SchmelterConsultant
Roberto KhouryExecutive Vice President and Chief Commercial Officer
Abbie LennoxExecutive Vice President and Chief Scientific Officer
Bradley JosephVice President of Global Investor Relations and Corporate Communications
Charles AtkinsonExecutive Vice President, General Counsel and Secretary
Robert WillisChief Human Resources Officer and Executive Vice President
Dr. David BallExecutive Vice President and Chief Brand and Digital Officer

Latest SEC Filings

DateTypeTitle
Jul 14, 20258-KCurrent Report
Jul 1, 20258-KCurrent Report
Jun 26, 202511-KAnnual report of employee stock purchase, savings and similar plans
Jun 6, 2025SCHEDULE 13G/AFiling
Jun 5, 2025144Filing
Jun 4, 20258-KCurrent Report
May 16, 2025SDForm - SD
May 14, 2025SCHEDULE 13G/AFiling
May 13, 2025SCHEDULE 13GFiling
May 7, 2025S-8Securities to be offered to employees in employee benefit plans